Global Pharmaceuticals & Biotech Most Popular Stocks

Kane Biotech

Market Cap: CA$8.3m

A biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.

Enzon Pharmaceuticals

Market Cap: US$5.9m

Does not have significant operations.

Unified Global

Market Cap: US$5.9m

Operates as a vertically integrated cannabis company in Canada and the United States.

Galecto

Market Cap: US$5.9m

A clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.

Quantum Genomics Société Anonyme

Market Cap: €5.0m

A healthtech company, develops of drugs to treat cardiovascular diseases.

Malaysian Genomics Resource Centre Berhad

Market Cap: RM 24.7m

Provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide.

Rakovina Therapeutics

Market Cap: CA$8.1m

A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.

Calidi Biotherapeutics

Market Cap: US$5.8m

A clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States.

Cannabis Bioscience International Holdings

Market Cap: US$5.8m

Cannabis Bioscience International Holdings, Inc.

Clearmind Medicine

Market Cap: US$5.8m

A clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.

Lamdong Pharmaceutical

Market Cap: ₫152.1b

Provides herbal products in Vietnam and internationally.

Strategic Partners

Market Cap: DKK 36.7m

Does not have significant operations.

Shelter Pharma

Market Cap: ₹508.6m

Manufactures and sells pharmaceutical products for human and animals in India.

Biotika

Market Cap: €4.9m

Operates as a pharmaceutical manufacturing company in Slovakia and internationally.

60 Degrees Pharmaceuticals

Market Cap: US$5.7m

A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.

SPM

Market Cap: ₫147.3b

Manufactures and sells pharmaceutical products in Vietnam.

BioLight Life Sciences

Market Cap: ₪18.8m

An ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions.

Ayurcann Holdings

Market Cap: CA$7.8m

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.

Mosaic ImmunoEngineering

Market Cap: US$5.6m

A development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.

Incanthera

Market Cap: UK£4.1m

A dermatology and oncology therapeutics company, focuses on the dermatological formulation and delivery technologies for various indications.

Alaunos Therapeutics

Market Cap: US$5.5m

A clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders.

RedHill Biopharma

Market Cap: US$5.5m

A specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases.

CordovaCann

Market Cap: US$5.5m

Engages in identifying, funding, developing, and managing operations in the cannabis value chain business.

Mystic Holdings

Market Cap: US$5.5m

Through its subsidiaries, engages in the cultivation, production, and wholesale of medical and recreational cannabis in Nevada, the United States.

Telo Genomics

Market Cap: CA$7.5m

A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada.

Tipharco Pharmaceutical

Market Cap: ₫141.2b

Manufactures and sells pharmaceuticals, medicinal chemicals, and botanical products.

cbdMD

Market Cap: US$5.4m

Produces and distributes various cannabidiol (CBD) products in the United States.

Titan Pharmaceuticals

Market Cap: US$5.4m

Does not have significant operations.

Mainz Biomed

Market Cap: US$5.3m

Develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe.

Blueberries Medical

Market Cap: CA$7.4m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

Pasithea Therapeutics

Market Cap: US$5.3m

A clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers.

Oragenics

Market Cap: US$5.3m

A development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States.

Aptevo Therapeutics

Market Cap: US$5.3m

A clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.

genXone

Market Cap: zł19.1m

Operates in the biotechnology industry in Poland and internationally.

Filament Health

Market Cap: US$5.2m

Operates as a clinical-stage natural psychedelic drug development company in Canada.

InMed Pharmaceuticals

Market Cap: US$5.2m

A clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States.